MEDGENICS INC (MDGN) Stock Price, Quote, News and Overview
NYSEARCA:MDGN - NYSE Arca - US58436Q2030
MDGN Quote, Performance and Key Statistics
5.57
+0.17 (+3.15%)
The current stock price of MDGN is 5.57 null. In the past month the price decreased by -1.59%. In the past year, price decreased by -10.45%.
About MDGN
Company Profile
Medgenics, Inc. is a medical technology and therapeutics company focused on providing sustained protein therapies. The Company's Biopump Platform Technology uses the patient's own tissue for the treatment of a range of chronic diseases. Its products include EPODURE focused on the treatment of chronic renal anemia and INFRADURE focused on the treatment of hepatitis C. Medgenics, Inc. is based in Vienna, Virginia.
Company Info
MEDGENICS INC
C/O MEDGENICS INC. 435 DEVON PARK DRIVE BLDG 700
WAYNE PA 19087
CEO: Michael F. Cola
Phone: 610-254-4201
MEDGENICS INC / MDGN FAQ
What is the stock price of MEDGENICS INC today?
The current stock price of MDGN is 5.57 null. The price increased by 3.15% in the last trading session.
What is the ticker symbol for MEDGENICS INC stock?
The exchange symbol of MEDGENICS INC is MDGN and it is listed on the NYSE Arca exchange.
On which exchange is MDGN stock listed?
MDGN stock is listed on the NYSE Arca exchange.
What is MEDGENICS INC worth?
MEDGENICS INC (MDGN) has a market capitalization of 206.54M null. This makes MDGN a Micro Cap stock.
What are the support and resistance levels for MEDGENICS INC (MDGN) stock?
MEDGENICS INC (MDGN) has a support level at 5.43 and a resistance level at 5.64. Check the full technical report for a detailed analysis of MDGN support and resistance levels.
Should I buy MEDGENICS INC (MDGN) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of MDGN, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of MDGN, evaluating the profitability, health, valuation and growth aspects
- MEDGENICS INC (MDGN) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- MEDGENICS INC (MDGN) Sales and EPS estimates to see what analysts future expectations are.
- MEDGENICS INC (MDGN) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- MEDGENICS INC (MDGN) Insider and Institutional Ownership to learn about the owners and their transactions.
- MEDGENICS INC (MDGN) Stock Chart to make your own analysis
- MEDGENICS INC (MDGN) Latest news and press-releases to stay up to date.
Does MEDGENICS INC (MDGN) stock pay dividends?
MDGN does not pay a dividend.
What is the Price/Earnings (PE) ratio of MEDGENICS INC (MDGN)?
MEDGENICS INC (MDGN) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.23).
MDGN Technical Analysis
ChartMill assigns a technical rating of 2 / 10 to MDGN. When comparing the yearly performance of all stocks, MDGN is a bad performer in the overall market: 61.16% of all stocks are doing better.
MDGN Financial Highlights
Over the last trailing twelve months MDGN reported a non-GAAP Earnings per Share(EPS) of -1.23. The EPS decreased by -5.53% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -78.57% | ||
| ROE | -85.7% | ||
| Debt/Equity | 0 |